Individual patient data meta-analysis of survival data using Poisson regression models

被引:68
|
作者
Crowther, Michael J. [2 ]
Riley, Richard D. [1 ]
Staessen, Jan A. [3 ,4 ]
Wang, Jiguang [5 ]
Gueyffier, Francois [6 ]
Lambert, Paul C. [2 ,7 ]
机构
[1] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester LE1 7RH, Leics, England
[3] Univ Leuven, Dept Cardiovasc Res, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, BE-3000 Louvain, Belgium
[4] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands
[5] Shanghai Jiao Tong Univ, Ruijin Hosp, Ctr Epidemiol Studies & Clin Trials, Shanghai 200025, Peoples R China
[6] INSERM, CIC201, F-69000 Lyon, France
[7] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden
来源
关键词
PARTICIPANT DATA; META-REGRESSION; TIME; HETEROGENEITY; HAZARDS; TRIALS; FRAMEWORK; LEVEL; BIAS;
D O I
10.1186/1471-2288-12-34
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for synthesising survival data from clinical trials. An IPD meta-analysis can be achieved by either a two-stage or a one-stage approach, depending on whether the trials are analysed separately or simultaneously. A range of one-stage hierarchical Cox models have been previously proposed, but these are known to be computationally intensive and are not currently available in all standard statistical software. We describe an alternative approach using Poisson based Generalised Linear Models (GLMs). Methods: We illustrate, through application and simulation, the Poisson approach both classically and in a Bayesian framework, in two-stage and one-stage approaches. We outline the benefits of our one-stage approach through extension to modelling treatment-covariate interactions and non-proportional hazards. Ten trials of hypertension treatment, with all-cause death the outcome of interest, are used to apply and assess the approach. Results: We show that the Poisson approach obtains almost identical estimates to the Cox model, is additionally computationally efficient and directly estimates the baseline hazard. Some downward bias is observed in classical estimates of the heterogeneity in the treatment effect, with improved performance from the Bayesian approach. Conclusion: Our approach provides a highly flexible and computationally efficient framework, available in all standard statistical software, to the investigation of not only heterogeneity, but the presence of non-proportional hazards and treatment effect modifiers.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Covariate heterogeneity in meta-analysis: Criteria for deciding between meta-regression and individual patient data
    Simmonds, M. C.
    Higgins, J. P. T.
    STATISTICS IN MEDICINE, 2007, 26 (15) : 2982 - 2999
  • [22] An individual patient data meta-analysis on the effect of chemotherapy on survival in patients with craniofacial osteosarcoma
    Liang, Lizhong
    Zhang, Tonghan
    You, Yingying
    He, Qifen
    Fan, Yunping
    Liao, Guiqing
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 2016 - 2023
  • [23] Bayesian multivariate skew meta-regression models for individual patient data
    Ibrahim, Joseph G.
    Kim, Sungduk
    Chen, Ming-Hui
    Shah, Arvind K.
    Lin, Jianxin
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2019, 28 (10-11) : 3415 - 3436
  • [24] Prospective meta-analysis using individual patient data in intensive care medicine
    Reade, Michael C.
    Delaney, Anthony
    Bailey, Michael J.
    Harrison, David A.
    Yealy, Donald M.
    Jones, Peter G.
    Rowan, Kathryn M.
    Bellomo, Rinaldo
    Angus, Derek C.
    INTENSIVE CARE MEDICINE, 2010, 36 (01) : 11 - 21
  • [25] Prospective meta-analysis using individual patient data in intensive care medicine
    Michael C. Reade
    Anthony Delaney
    Michael J. Bailey
    David A. Harrison
    Donald M. Yealy
    Peter G. Jones
    Kathryn M. Rowan
    Rinaldo Bellomo
    Derek C. Angus
    Intensive Care Medicine, 2010, 36 : 11 - 21
  • [26] Meta-analysis of continuous outcomes combining individual patient data and aggregate data
    Riley, Richard D.
    Lambert, Paul C.
    Staessen, Jan A.
    Wang, Jiguang
    Gueyffier, Francois
    Thijs, Lutgarde
    Boutitie, Florent
    STATISTICS IN MEDICINE, 2008, 27 (11) : 1870 - 1893
  • [27] Meta-analysis of a continuous outcome combining individual patient data and aggregate data: a method based on simulated individual patient data
    Yamaguchi, Yusuke
    Sakamoto, Wataru
    Goto, Masashi
    Staessen, Jan A.
    Wang, Jiguang
    Gueyffier, Francois
    Riley, Richard D.
    RESEARCH SYNTHESIS METHODS, 2014, 5 (04) : 322 - 351
  • [28] Multivariate meta-analysis for data consortia, individual patient meta-analysis, and pooling projects
    Ritz, John
    Demidenko, Eugene
    Spiegelman, Donna
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2008, 138 (07) : 1919 - 1933
  • [29] Survival Meta-Analysis of Individual Patient Data and Survival Meta-Analysis of Published (Aggregate) DataIs There an Intermediate Approach between these Two Opposite Options?
    Andrea Messori
    Sabrina Trippoli
    Monica Vaiani
    Francesco Cattel
    Clinical Drug Investigation, 2000, 20 : 309 - 316
  • [30] Comparison of One-Step and Two-Step Meta-Analysis Models Using Individual Patient Data
    Mathew, Thomas
    Nordstrom, Kenneth
    BIOMETRICAL JOURNAL, 2010, 52 (02) : 271 - 287